Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis
- PMID: 1398968
- PMCID: PMC258203
- DOI: 10.1128/iai.60.11.4563-4570.1992
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis
Abstract
A group of mice was aerosol infected with live, virulent Bordetella pertussis bacteria. During a period of 7 weeks following the infection, with intervals of 1 week, lymphocytes were isolated from the tracheobroncheal lymph nodes (TBL) and the spleens (SPL) of the infected mice. The in vitro proliferative responses as well as the gamma interferon and tumor necrosis factor production levels of the isolated lymphocytes in response to stimulation with whole killed B. pertussis bacteria were measured as parameters for cell-mediated immunity (CMI). The course of the infection was monitored by counting of CFU in the lungs of the mice. Moreover, antibody responses in serum against a range of B. pertussis antigens were assessed. The results showed that a vigorous proliferative response of the TBL and SPL to stimulation with whole killed B. pertussis bacteria was induced by the infection. The proliferative response of the TBL was significantly higher than the response of the SPL. The proliferative responses were maximal 3 to 4 weeks after the infection and were paralleled by in vitro gamma interferon and tumor necrosis factor production upon specific stimulation. The development of the CMI was observed simultaneously with the clearance of the infection from the lungs. Antibody responses became measurable in the sera only after the infection was cleared. A specific CMI against pertussis toxin, the filamentous hemagglutinin, the 69-kDa outer membrane protein, and the agglutinogens 2 and 3, antigens which are under consideration for inclusion in future acellular pertussis vaccines, was successfully demonstrated in mice 3 weeks after the infection.
Similar articles
-
Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.Infect Immun. 2001 Nov;69(11):6981-6. doi: 10.1128/IAI.69.11.6981-6986.2001. Infect Immun. 2001. PMID: 11598073 Free PMC article.
-
Long-lived respiratory immune response to filamentous hemagglutinin following Bordetella pertussis infection.Infect Immun. 1993 Apr;61(4):1447-52. doi: 10.1128/iai.61.4.1447-1452.1993. Infect Immun. 1993. PMID: 8454349 Free PMC article.
-
Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes.J Exp Med. 1997 Dec 1;186(11):1843-51. doi: 10.1084/jem.186.11.1843. J Exp Med. 1997. PMID: 9382883 Free PMC article.
-
Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.Vaccine. 2004 Oct 22;22(31-32):4270-81. doi: 10.1016/j.vaccine.2004.04.033. Vaccine. 2004. PMID: 15474718
-
Evaluation of efficacy in terms of antibody levels and cell-mediated immunity of acellular pertussis vaccines in a murine model of respiratory infection.FEMS Immunol Med Microbiol. 2002 Jul 12;33(3):219-25. doi: 10.1111/j.1574-695X.2002.tb00594.x. FEMS Immunol Med Microbiol. 2002. PMID: 12110485
Cited by
-
Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.Infect Immun. 1993 Aug;61(8):3190-8. doi: 10.1128/iai.61.8.3190-3198.1993. Infect Immun. 1993. PMID: 8335349 Free PMC article.
-
Bordetella bronchiseptica-Mediated Interference Prevents Influenza A Virus Replication in the Murine Nasal Cavity.Microbiol Spectr. 2023 Feb 2;11(2):e0473522. doi: 10.1128/spectrum.04735-22. Online ahead of print. Microbiol Spectr. 2023. PMID: 36728413 Free PMC article.
-
Circulating fibronectin and fibronectin receptor in children with pertussis.J Clin Pathol. 1994 Sep;47(9):793-5. doi: 10.1136/jcp.47.9.793. J Clin Pathol. 1994. PMID: 7962645 Free PMC article.
-
Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection.Infect Immun. 1999 Nov;67(11):6109-18. doi: 10.1128/IAI.67.11.6109-6118.1999. Infect Immun. 1999. PMID: 10531274 Free PMC article.
-
Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production.J Exp Med. 2000 Jun 5;191(11):1841-52. doi: 10.1084/jem.191.11.1841. J Exp Med. 2000. PMID: 10839801 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical